Navigation Links
Hazardous medications
Date:2/17/2012

More than one in four elderly patients was given potentially hazardous medication during 2007. That is the conclusion of a study by Ute Amann and her co-authors in the current issue of the Deutsches rzteblatt International (Dtsch Arztebl Int 2012; 109[5]: 69-75).

Giving certain medical drug substances to over-65-year-olds can increase the risk of undesired drug effects, and for this reason experts describe them as "potentially inappropriate medications" (PIMs).

This study used information from a large database to attempt to estimate the risk of PIM for older people according to age, sex, and drug substance. The researchers used the data of 447 592 men and 356 808 women aged 65 or over to assess how often PIMs were prescribed per patient.

Women had more PIM prescriptions than men. The potentially hazardous drugs that were most often prescribed were amitriptyline, acetyldigoxin, tetrazepam, and oxazepam. Overall, 8.8% of all patients in the database received four or more prescriptions for the same or an equivalent drug during the study period.


'/>"/>
Contact: Deutsches rzteblatt International
medwiss@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related biology news :

1. Scented laundry products emit hazardous chemicals through dryer vents
2. Study suggests lower risk of coronary heart disease from alcohol, even with hazardous drinking
3. Binge drinking: Too prevalent and hazardous
4. LSU receives $3.6 million to fund center studying hazardous waste cleanup and health impacts
5. Webcam technology used to measure medications effects on the heart
6. Toward new medications for chronic brain diseases
7. Pathological gambling may be successfully treated with medications for substance addiction
8. New medications show promise in treating drug-resistant prostate cancer
9. Hypertension and cholesterol medications present in water released into the St. Lawrence River
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... 2017 , ... For the second time in three years, ... Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October 10th, ... mission is to change the trajectory of STEM education in America by dramatically ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
Breaking Biology Technology: